Background-Intermittent positive pressure ventilation applied through a nasal mask has been shown to be useful in the treatment of chronic respiratory insufficiency. Pressure support ventilation is an assisted mode of ventilation which is being increasingly used. Invasive ventilation with intermittent positive pressure, with or without positive end expiratory pressure (PEEP), has been found to affect venous return and cardiac output. This study evaluated the acute haemodynamic effects of short sessions of pressure support ventilation by nasal mask, with and without the application of PEEP, in patients with severe stable chronic obstructive pulmonary disease
Background-Intermittent positive pressure ventilation applied through a nasal mask has been shown to be useful in the treatment of chronic respiratory insufficiency. Pressure support ventilation is an assisted mode of ventilation which is being increasingly used. Invasive ventilation with intermittent positive pressure, with or without positive end expiratory pressure (PEEP), has been found to affect venous return and cardiac output. This study evaluated the acute haemodynamic effects of short sessions of pressure support ventilation by nasal mask, with and without the application of PEEP, in patients with severe stable chronic obstructive pulmonary disease and hypercapnia. Methods-Nine patients with severe stable chronic obstructive pulmonary disease performed sessions lasting 10 minutes each of pressure support ventilation by nasal mask while undergoing right heart catheterisation for clinical evaluation. In random order, four sessions of nasal pressure support ventilation were applied consisting of: (1) peak inspiratory pressure (PIP) 10 Intermittent positive pressure ventilation (IPPV) applied through a nasal mask has been shown to be useful in the treatment of chronic respiratory failure. It is usually delivered by standard volume cycled ventilators in assisted or control modes.' Continuous positive airway pressure (CPAP) administered by the nasal route has been suggested to facilitate respiratory muscle function during sleep in patients with severe chronic obstructive pulmonary disease (COPD).' Pressure support ventilation (PSV) supplies a constant level of positive airway pressure during spontaneous inspiratory efforts, allowing the patient to maintain control of inspiratory and expiratory time and to interact with the set pressure to determine the ultimate flow and tidal volume delivered.3 PSV has been used in different clinical situations6-9 and is being increasingly applied in acute respiratory failure with a facial mask.10 In patients with severe stable COPD, pressure support ventilation by nasal mask (NPSV) improves diaphragmatic function and alveolar ventilation" 12; this effect may be enhanced by the application of external positive end expiratory pressure (PEEP).12
Mechanical ventilation may adversely affect haemodynamics. Invasive IPPV, with or without the application of PEEP, has been found to affect venous return and cardiac output. [13] [14] [15] Other investigators have treated patients with chronic respiratory insufficiency with intermittent ventilation provided by negative pressure ventilators and different results on haemodynamics have been found with the iron lung, Cuirass or Ponchowrap ventilators. [16] [17] [18] [19] [20] [21] To our knowledge no information is available on the haemodynamic effects of noninvasive positive pressure ventilation apart from CPAP in patients with congestive heart failure. 22 USA) while seated. BIPAP is a nasal CPAP blower modified with a solenoid system that allows timed cyclical delivery of positive airway pressure at two different levels, both in "spontaneous" (assisted) and controlled mode; the details have been extensively described elsewhere." 24 In the "spontaneous" mode inspiratory positive peak inflation pressure (PIP) up to a maximum of 22 cm H20, and external PEEP can be set, but the patient triggers inspiration and expiration. In other words, pressure support ventilation can be delivered with the ability to add PEEP if required. NPSV was applied through a comfortable, tightly fitting nasal mask (Respironics, Monroeville, Pennsylvania USA).
On the two days preceding the haemodynamic studies patients underwent several learning sessions with different levels of PIP, with and without PEEP, by BIPAP in "spon- On the third day patients underwent pulmonary artery catheterisation. After baseline measurements were made in the supine position, they again performed the four different sessions of NPSV, each of 10 minutes' duration. NPSV sessions were delivered randomly with no interval between each session. By the percutaneous approach of Seldinger, a 7 Fr balloon tipped thermodilution pulmonary artery catheter (Edwards Laboratory, Santa Ana, California, USA) was positioned under fluoroscopy in one of the main pulmonary arteries. Filling pressures were measured in the standard manner and were zero referred to the level of the right atrium. The pulmonary artery pressure (PAP), right atrial pressure (RAP), pulmonary capillary wedge pressure (PWP), systemic blood pressure directly measured via a catheter inserted in the radial artery (Hewlett-Packard pressure conditioner HP 8805 D and transducer HP 1290 A), and the air pressure delivered at the mask (Honeywell transducer + 300 cm H20, Freeport, Illinois, USA) were continuously monitored and recorded on a polygraph (Gould ES 1000) together with the ECG.
Radial artery pressure tracings were available in seven of nine patients because of the difficulty of inserting an arterial catheter in two patients. Cardiac output was estimated by the standard thermodilution technique with a cardiac output computer (Edwards 9520A, Edwards Laboratory, Santa Ana, California, USA) and the average of three measurements was recorded.
All haemodynamic and blood gas measurements were made at baseline and during the final minute of each NPSV session.
Continuous monitoring of blood pressure, PAP, RAP, and ECG helped to ensure that, . (22) 75 (11) 76 (12) 76 (11) 74 (14) Cardiac output (1/min) 5-1 (0-6) 4 9 (0 9) 4-5 (0 6)* 4-7 (0 9) 4-2 (0 8)* PAP (mm Hg) 27 (6) 28 (6) 27 (6) 28 (6) 28 (6) PWP (mm Hg) 7 (2) 9 (2) 9 (2)* 11 (2)* 11 (2)* RAP (mm Hg) 3 (2) 4 29 compression, 9 the deleterious effects of positive pressure upon venous return are minimal in patients with poor left ventricular function since they have flat atrial pressure-volume curves. The net effect is therefore unchanged or improved haemodynamics. Left ventricular function in our patients may be indirectly inferred to be satisfactory by their relatively normal levels of PWP and cardiac output. In patients with normal left ventricular function the ventricular assist will be relatively small, but the effect on atrial filling will predominate thereby explaining the fall in cardiac output. In our study NPSV, with and without PEEP, induced haemodynamic changes and, in the short term, reduced Do2 in spite of the ability of NPSV to improve levels of blood gases. In a previous study" we observed that NPSV, at a PIP level of 20 cm H20 without PEEP, was able to increase significantly alveolar ventilation and Pao2. As found in an earlier study in patients with COPD,35 a reduced abdominothoracic gradient across the diaphragm could explain the reduction in cardiac output with the application of NPSV. NPSV induced haemodynamic changes comparable to those observed in intubated patients undergoing CPPV. In fact, cardiac output decreased significantly and a significant increase in PWP was observed, PVR remaining unchanged. In our study, however, the maximal decrease in cardiac output observed was 30% (in a patient ventilated with PIP of 20 cm H20 and PEEP of 5 cm H20), and overall the reductions in cardiac output seemed not to have clinical relevance, although they induced a consequent reduction in Do2. Biondi 38 and the four ventilatory modes were applied in succession and randomised to avoid any carry over effect. Furthermore, blood pressure, PAP, RAP, and ECG were recorded in real time during the study and at the moment of measurement these parameters were stable. An observation limited to 10 minutes of each mode of NPSV, however, may not be representative of a genuine therapeutic effect. This makes it difficult to draw conclusions about the addition of PEEP, as most patients with stable COPD would use NPSV for many hours overnight.
All patients showed a rapid drop in Paco2 on the institution of 20 cm H2O of PIP which may play a part in the haemodynamic changes seen. With longer use of ventilation, however, homeostatic mechanisms are likely to come into play.39 These include salt and water retention due to activation of the renin angiotensin system as a consequence of the reduced cardiac output, or a reduction in atrial natriuretic factor as a direct effect of PEEP on right atrial size. These mechanisms tend to increase cardiac filling pressures and restore cardiac output. Once a new stable level is reached, cardiac output and Do2 may improve. The important clinical implication of this study, however, is that Fio2 should be increased initially to improve Do2, even if arterial blood gas tensions are adequate, in an attempt to offset the fall in cardiac output. Lastly, two of the nine patients who performed the study were receiving oxygen. Increasing the Fio2 would influence PVR; nevertheless, oxygen was administered during both basal measurements and ventilation in order to maintain a Sao2 above 90%, so the relative changes in haemodynamic parameters should not have been greatly affected.
In conclusion, although the observed changes in haemodynamics had no effect on blood pressure and were not related to clinical signs, this study may suggest that the addition of PEEP to NPSV adds nothing to NPSV alone in improving oxygen delivery in stable patients with COPD.
